NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals Revenue

NovaBay Pharmaceuticals had revenue of $2.44M in the quarter ending September 30, 2024, a decrease of -1.61%. This brings the company's revenue in the last twelve months to $13.84M, up 15.40% year-over-year. In the year 2023, NovaBay Pharmaceuticals had annual revenue of $14.73M with 2.24% growth.

• Revenue (ttm): $13.84M
• Revenue Growth: +15.40%
• P/S Ratio: 0.07
• Revenue / Employee: $532,462
• Employees: 26
• Market Cap: 3.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	14.73M	322.00K	2.24%
Dec 31, 2022	14.40M	4.20M	41.16%
Dec 31, 2021	10.20M	270.00K	2.72%
Dec 31, 2020	9.93M	3.34M	50.54%
Dec 31, 2019	6.60M	-5.91M	-47.24%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.